Transvaginal NOTES Sleeve Gastrectomy
Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Trans-Vaginal Sleeve Gastrectomy
1 other identifier
observational
N/A
1 country
1
Brief Summary
This is a prospective chart review/data collection study of natural orifice translumenal endoscopic surgery (NOTES) for sleeve gastrectomy, that will include questionnaires administered throughout the study. Subjects enrolled will be those intending to have a transvaginal NOTES sleeve gastrectomy. Data will be collected and reviewed through 12 months post-op.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 21, 2011
CompletedFirst Posted
Study publicly available on registry
July 26, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedMarch 31, 2020
March 1, 2020
10 years
July 21, 2011
March 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess outcomes related to the transvaginal NOTES approach to laparoscopic sleeve gastrectomy (through data collection).
1 year
Secondary Outcomes (1)
To assess pain associated with the transvaginal NOTES approach to laparoscopic sleeve gastrectomy (through data collection).
1 year
Study Arms (1)
Transvaginal NOTES sleeve gastrectomy
Transvaginal NOTES sleeve gastrectomy
Interventions
transvaginal NOTES sleeve gastrectomy
Eligibility Criteria
Patients between the ages of 18-75 who present in the UC San Diego Surgical Specialties clinic and have been cleared by the Bariatric and Metabolic Institute (BMI) team for bariatric surgery will be evaluated for participation in this trial. If the inclusion and exclusion criteria are met, the patients will be offered participation in the trial.
You may qualify if:
- Diagnosis of morbid obesity BMI \> 40
- Female, age 18-75
- Mentally competent to give informed consent
- Scheduled to undergo a transvaginal NOTES sleeve gastrectomy
You may not qualify if:
- Pregnant women
- BMI \< 40
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Diego
San Diego, California, 92103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Santiago Horgan, M.D., FACS
UCSD
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
July 21, 2011
First Posted
July 26, 2011
Study Start
October 1, 2008
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
March 31, 2020
Record last verified: 2020-03